EBOS Group Ltd
ASX:EBO
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| NZ |
|
EBOS Group Ltd
NZX:EBO
|
4.9B NZD |
Loading...
|
|
| US |
|
Mckesson Corp
NYSE:MCK
|
120.4B USD |
Loading...
|
|
| US |
|
Cencora Inc
NYSE:COR
|
72.4B USD |
Loading...
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
71.3B USD |
Loading...
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
53.6B USD |
Loading...
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
32.7B AUD |
Loading...
|
|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.8B USD |
Loading...
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.9B CNY |
Loading...
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
62.7B CNY |
Loading...
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW |
Loading...
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
66B HKD |
Loading...
|
Market Distribution
| Min | -127.6% |
| 30th Percentile | 37.1% |
| Median | 51% |
| 70th Percentile | 64.7% |
| Max | 107.2% |
Other Profitability Ratios
EBOS Group Ltd
Glance View
In the sprawling landscape of the Australasian healthcare and animal care markets, EBOS Group Ltd. stands as a towering presence, orchestrating a symphony of operations that span distribution, logistics, and retail. Established decades ago, EBOS has meticulously expanded its footprint to become a vital linchpin in the supply chain of healthcare and animal care products. Understanding its core operations is akin to peering into a well-oiled machine where efficiency reigns supreme. At the heart of EBOS's business model is its distribution segment, which acts as a conduit for pharmaceutical and healthcare products from manufacturers to a diverse range of clients including hospitals, pharmacies, and aged care facilities. This seamless distribution network is supported by state-of-the-art logistics capabilities, enabling the company to ensure timely and reliable delivery of crucial healthcare supplies across the region. Beyond distribution, EBOS has judiciously diversified into animal care and retail, recognizing the intertwining of human and animal welfare in contemporary lifestyles. Its procurement and distribution of veterinary products capitalize on the robust and growing pet care market, which has seen a surge in demand as households increasingly consider pets as part of the family. The company's retail arm, featuring well-known banners like TerryWhite Chemmart, brings it closer to consumers, providing a direct link to end-users and fortifying its revenue streams. By embracing these complementary business segments, EBOS not only ensures a balanced portfolio but also leverages synergies to maximize profit margins. Thus, through a blend of comprehensive distribution networks and strategic retail positions, EBOS Group Ltd. adeptly maneuvers within its markets, translating efficiency and scale into consistent, sustainable growth.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for EBOS Group Ltd is 13.3%, which is above its 3-year median of 12.7%.
Over the last 3 years, EBOS Group Ltd’s Gross Margin has increased from 11.5% to 13.3%. During this period, it reached a low of 11.5% on Jun 30, 2022 and a high of 13.3% on Jun 30, 2025.